Literature DB >> 28808928

Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons.

Saravanan Arumugam1, Stefka Mincheva-Tasheva1, Ambika Periyakaruppiah1, Sandra de la Fuente1, Rosa M Soler2, Ana Garcera1.   

Abstract

Survival motor neuron (SMN) protein deficiency causes the genetic neuromuscular disorder spinal muscular atrophy (SMA), characterized by spinal cord motoneuron degeneration. Since SMN protein level is critical to disease onset and severity, analysis of the mechanisms involved in SMN stability is one of the central goals of SMA research. Here, we describe the role of several members of the NF-κB pathway in regulating SMN in motoneurons. NF-κB is one of the main regulators of motoneuron survival and pharmacological inhibition of NF-κB pathway activity also induces mouse survival motor neuron (Smn) protein decrease. Using a lentiviral-based shRNA approach to reduce the expression of several members of NF-κB pathway, we observed that IKK and RelA knockdown caused Smn reduction in mouse-cultured motoneurons whereas IKK or RelB knockdown did not. Moreover, isolated motoneurons obtained from the severe SMA mouse model showed reduced protein levels of several NF-κB members and RelA phosphorylation. We describe the alteration of NF-κB pathway in SMA cells. In the context of recent studies suggesting regulation of altered intracellular pathways as a future pharmacological treatment of SMA, we propose the NF-κB pathway as a candidate in this new therapeutic approach.

Entities:  

Keywords:  Motoneurons; NF-kappaB; RelA; SMN; Spinal muscular atrophy

Mesh:

Substances:

Year:  2017        PMID: 28808928     DOI: 10.1007/s12035-017-0710-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  45 in total

1.  Specific vulnerability of mouse spinal cord motoneurons to membrane depolarization.

Authors:  Myriam Gou-Fabregas; Ana Garcera; Stefka Mincheva; M Jose Perez-Garcia; Joan X Comella; Rosa M Soler
Journal:  J Neurochem       Date:  2009-07-13       Impact factor: 5.372

2.  Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation.

Authors:  M Nakai; Z H Qin; J F Chen; Y Wang; T N Chase
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

Review 3.  IKK biology.

Authors:  Fei Liu; Yifeng Xia; Aaron S Parker; Inder M Verma
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

4.  Regulation of beta-catenin function by the IkappaB kinases.

Authors:  C Lamberti; K M Lin; Y Yamamoto; U Verma; I M Verma; S Byers; R B Gaynor
Journal:  J Biol Chem       Date:  2001-08-29       Impact factor: 5.157

5.  Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Casey J Lumpkin; Ashlee W Harris; Luciano Saieva; Jonathan D Edwards; Eileen Workman; Louise R Simard; Livio Pellizzoni; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2016-02-15       Impact factor: 5.330

6.  Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes.

Authors:  Eleonora Olivotto; Rosa Maria Borzi; Roberta Vitellozzi; Stefania Pagani; Annalisa Facchini; Michela Battistelli; Marianna Penzo; Xiang Li; Flavio Flamigni; Jun Li; Elisabetta Falcieri; Andrea Facchini; Kenneth B Marcu
Journal:  Arthritis Rheum       Date:  2008-01

7.  Nuclear factor kappa B signaling either stimulates or inhibits neurite growth depending on the phosphorylation status of p65/RelA.

Authors:  Humberto Gutierrez; Gerard W O'Keeffe; Núria Gavaldà; Denis Gallagher; Alun M Davies
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

8.  Glial cell line-derived neurotrophic factor increases intracellular calcium concentration. Role of calcium/calmodulin in the activation of the phosphatidylinositol 3-kinase pathway.

Authors:  M José Pérez-García; Valentín Ceña; Yolanda de Pablo; Marta Llovera; Joan X Comella; Rosa M Soler
Journal:  J Biol Chem       Date:  2003-11-20       Impact factor: 5.157

9.  Constitutive nuclear factor-kappa B activity is required for central neuron survival.

Authors:  Asha L Bhakar; Laura-Lee Tannis; Christine Zeindler; Maria Pia Russo; Christian Jobin; David S Park; Sandra MacPherson; Philip A Barker
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

10.  Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells.

Authors:  Barbara Kaltschmidt; Michael Heinrich; Christian Kaltschmidt
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

View more
  5 in total

Review 1.  Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.

Authors:  Natalia N Singh; Shaine Hoffman; Prabhakara P Reddi; Ravindra N Singh
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-05       Impact factor: 5.187

2.  Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice.

Authors:  Roberta Schellino; Marina Boido; Tiziana Borsello; Alessandro Vercelli
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 5.639

3.  SMN deficiency causes pain hypersensitivity in a mild SMA mouse model through enhancing excitability of nociceptive dorsal root ganglion neurons.

Authors:  Ruobing Qu; Fuping Yao; Xiaomin Zhang; Yuan Gao; Tong Liu; Yimin Hua
Journal:  Sci Rep       Date:  2019-04-24       Impact factor: 4.379

Review 4.  Disrupted neuronal trafficking in amyotrophic lateral sclerosis.

Authors:  Katja Burk; R Jeroen Pasterkamp
Journal:  Acta Neuropathol       Date:  2019-02-05       Impact factor: 17.088

Review 5.  Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment.

Authors:  Giovanna Menduti; Daniela Maria Rasà; Serena Stanga; Marina Boido
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.